Italian researchers say that the weight loss medication Acomplia could be effective in helping people addicted to chocolate to stop eating it.
The research which was done at the Institute of Neuroscience based in Cagliari involved the use of mice in …
Acomplia (Rimonabant) - Effective weight loss and anti-obesity medication
Obesity is excessive accumulation of adipose tissue within the body, which exceeds the body’s skeletal and physical standards. Obesity is now recognized as a serious chronic disease, which not only affects your …
Weight loss has been the most talked about topic all over the world. From U.S. to Australia, Asia to Africa, the civilized world is wrestling with weight loss. Scientists, across the globe are constantly inventing new ways to speed …
As soon as Spring starts to appear in full force the thoughts of losing weight in preparation for summer appear in everyone’s head. This is normally closely followed by the terrifying thought of having to fit into a bikini …
Purchase Acomplia (Rimonabant), the new age weight loss drug which is developed by world’s third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese population across the world. Acomplia Rimonabant (Acomplia/Zimulti) is recommend to those …
Rimonabant is a new entrant in the market of weight loss. Clinically it has been proved that Rimonabant is a selective CB1 Endocannabinoid receptor antagonist indicated for the treatment of obesity and is very effective in stopping one’s urge on …
Acomplia diet pill is basically an anorectic oral prescription. The active ingredient present in it is rimonabant which helps people in decreasing unnecessary fat from body. Diet pill Acomplia works by targeting the CB-1 receptors, which regulates one’s appetite, and …
In the absence of a right treatment, obesity grows gradually. Acomplia, the new invention of Sanofi, not only controls obesity but also it helps in curbing urge for smoking. Acomplia, the high efficacy oral-prescription medication is available through an online …